Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0XXQUG)
| ADC Name |
SHR-4375
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
SHR-4375
Click to Show/Hide
|
|||||
| Organization |
Jiangsu Hengrui Pharmaceuticals (Originator)
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Antibody Name |
Anti-tissue factor antibody
|
Antibody Info | ||||
| Antigen Name |
Tissue factor (F3)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Payload Target |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC